Side-by-side comparison of AI visibility scores, market position, and capabilities
TYO: 6758 / NYSE: SONY global entertainment and technology conglomerate at ~$85.75B FY2025 revenue with PS5 (74.9M units), Sony Music, and 40%+ smartphone sensor market share competing across gaming, music, and semiconductors.
Sony Group Corporation is a Tokyo, Japan-based global technology and entertainment conglomerate — listed on the Tokyo Stock Exchange (TYO: 6758) and NYSE (NYSE: SONY) — operating across six business segments: Game & Network Services (PlayStation 5 console, PlayStation Network, PlayStation Studios), Music (Sony Music Entertainment, the world's second-largest record label), Pictures (Sony Pictures Entertainment, Columbia Pictures, TriStar), Electronics Products & Solutions (TVs, cameras, audio, mobile), Imaging & Sensing Solutions (camera image sensors for smartphones), and Financial Services (Sony Financial Group). Sony generated JPY 4.41 trillion ($28.6B USD) in Q3 FY2024 revenue (+18% year-over-year) with a FY2025 full-year revenue outlook of approximately $85.75 billion and $7.01 billion in net income.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.